Test Price
2,800 AED✅ Home Collection Available
HS6ST1 Gene Hypogonadotropic Hypogonadism Type 15 (With/Without Anosmia) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين HS6ST1 لقصور الغدد التناسلية الناجم عن نقص الهرمونات الموجهة للغدد التناسلية من النوع 15 مع أو بدون فقدان الشم – الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary & Clinical Assurance
يقدم هذا التحليل الجيني المتقدم تقييمًا تشخيصيًا دقيقًا للطفرات في جين HS6ST1، المسؤول عن الشكل الوراثي لقصور الغدد التناسلية. نضمن أعلى معايير الدقة من خلال مختبرنا المعتمد عالميًا وفقًا لمعيار ISO 9001:2015، مع توفير خدمة سحب العينات المنزلية لكامل راحتك وسلامتك.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity and Specificity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid Hospital-Grade Home Collection – ISO Certified Cold-Chain transport and VIP Mobile Phlebotomy Services, available 8 AM to 11 PM daily.
- Clinical Guidance: Comprehensive telephonic post-test clinical guidance provided for accurate result interpretation and familial risk counseling.
- Insurance Support: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Overview: Precision Genomic Diagnostics for Reproductive Endocrinology
The HS6ST1 Gene NGS test utilizes Next-Generation Sequencing to definitively diagnose Type 15 Hypogonadotropic Hypogonadism, a genetic disorder affecting pubertal development and fertility, often associated with anosmia (Kallmann syndrome). This targeted analysis identifies clinically actionable variants, empowering precise medical management for patients across the UAE.
| Feature | Our Test (DHA-Licensed) | Closest Alternative |
|---|---|---|
| Precision / Methodology | Full Gene NGS Sequencing (99.9% Coverage) | Panel Sequencing or Single Exon Analysis |
| Clinical Utility | Comprehensive Variant Detection (SNVs, Indels) | Limited to predefined hot-spots |
| Turnaround Time | 3 to 4 Weeks | 6 to 8 Weeks (Standard) |
Physician Insight & Safety Protocol
"As a clinical endocrinologist, I recognize that the journey to a confirmed genetic diagnosis for hypogonadotropic hypogonadism is deeply personal and often emotional for patients and families. This test provides a definitive molecular answer, but the results must always be correlated with your full clinical picture, hormone profiles, and imaging studies. I commend you for taking this proactive step toward understanding your reproductive health."
— Dr. PRABHAKAR REDDY, DHA License: 61713011
Do not discontinue any prescribed hormonal therapy, including gonadotropins, testosterone, or estradiol, without explicit consultation with your supervising physician. Abrupt cessation can precipitate acute endocrine decompensation.
Patient Safety & Exclusion Criteria
Exclusion for Home Collection: Patients with active febrile illness (>38.0°C), acute cardiovascular instability, or those requiring continuous supplemental oxygen are not eligible for home-based phlebotomy and should visit a hospital facility.
Emergency Red Flags: If you experience sudden severe testicular or pelvic pain, visual field disturbances, or profound hypotension, seek immediate emergency medical attention rather than proceeding with a routine genetic test.
Frequently Asked Patient Questions & Clinical Guidance
How will this test definitively confirm if my pubertal delay is caused by an HS6ST1 gene mutation?
This NGS test definitively identifies disease-causing variants in the HS6ST1 gene by sequencing its entire coding region, providing a molecular diagnosis for Type 15 Hypogonadotropic Hypogonadism with or without anosmia.
يحدد هذا الاختبار المتقدم باستخدام تقنية التسلسل الجيني المتقدم (NGS) المتغيرات المسببة للمرض في كامل المنطقة المشفرة لجين HS6ST1، مما يوفر تشخيصًا جزيئيًا دقيقًا لقصور الغدد التناسلية من النوع 15.
What is the clinical utility of carrier screening for relatives in families affected by infertility?
Identifying the familial HS6ST1 variant enables accurate carrier testing for at-risk siblings, guiding reproductive planning and early hormonal intervention to optimize pubertal outcomes.
يسمح تحديد المتغير الجيني العائلي في جين HS6ST1 بإجراء اختبار دقيق لحمل الجين للأشقاء المعرضين للخطر، مما يوجه التخطيط الإنجابي والتدخل الهرموني المبكر لتحسين نتائج البلوغ.
How does the mandated pre-test genetic counseling session protect my family's data privacy in the UAE?
The mandatory pre- genetic counseling session, conducted under strict adherence to UAE PDPL (Federal Decree-Law No. 41 of 2024), ensures fully informed consent and explains how your genomic data is anonymized and secured.
تضمن جلسة الاستشارة الوراثية الإلزامية، التي تُجرى بموجب الالتزام الصارم بقانون حماية البيانات الشخصية الإماراتي (المرسوم بقانون اتحادي رقم 41 لسنة 2024)، الموافقة المستنيرة الكاملة وتشرح كيفية إخفاء هوية بياناتك الجينومية وتأمينها.
UAE Healthcare Regulatory Compliance:
This service strictly adheres to Federal Decree-Law No. 41 of 2024 (Art. 87) on Data Protection, the UAE CDS Law 2026 concerning minors, and is performed by a DHA-licensed facility (License: 9834453). All genetic counseling is mandatory and confidential.
ISO Credentials: ISO 9001:2015 Quality Management System Certified (Cert: INT/EGQ/2509DA/3139).
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians